TABLE 2

Blood Values and Clinical Results

Patient no.	Hemoglobin (g/L)					Thrombocytes (×10⁹/L)					Creatinine (μmol/L)					Clinical result after treatment with ¹⁷⁷Lu-DOTATOC
Patient no.		Before ⁹⁰Y-DOTATOC treatment	Before ¹⁷⁷Lu-DOTATOC treatment	After ¹⁷⁷Lu-DOTATOC treatment	Before ⁹⁰Y-DOTATOC treatment	Before ¹⁷⁷Lu-DOTATOC treatment	After ¹⁷⁷Lu-DOTATOC treatment	Before ⁹⁰Y-DOTATOC treatment	Before ¹⁷⁷Lu-DOTATOC treatment	After ¹⁷⁷Lu-DOTATOC treatment						Clinical result after treatment with ¹⁷⁷Lu-DOTATOC
1	104	87	72	406	372	206	83	133	118	Stable disease
2	116	102	105	176	188	143	77	117	124	Stable disease
3	133	115	115	302	251	122	68	94	62	Progressive disease
4	116	115	108	285	188	200	60	111	75	Progressive disease
5	127	119	116	129	173	95	52	65	70	Partial remission
6	107	107	109	311	152	133	54	59	62	Stable disease
7	115	100	102	268	239	108	33	60	63	Progressive disease
8	133	116	115	218	303	190	45	58	43	Minor response
9	145	137	116	226	182	132	74	96	97	Minor response
10	135	134	115	218	214	329	61	58	68	Minor response
11	111	110	112	679	299	127	57	62	61	Minor response
12	136	123	128	227	462	252	61	84	82	Stable disease
13	126	127	112	275	234	208	71	88	84	Progressive disease
14	160	140	135	243	244	219	71	96	114	Progressive disease
15	110	105	80	348	187	109	65	197	167	Partial remission
16	141	109	104	241	282	241	70	137	112	Stable disease
17	146	131	130	279	245	239	88	90	102	Minor response
18	149	102	114	455	366	215	69	120	104	Stable disease
19	124	129	129	521	334	243	49	51	64	Stable disease
20	140	128	126	404	158	138	77	128	111	Stable disease
21	134	100	101	237	329	283	57	248	269	Stable disease
22	144	114	123	339	409	342	81	88	120	Progressive disease
23	146	123	118	231	162	157	65	73	71	Stable disease
24	137	103	118	218	225	186	78	101	97	Progressive disease
25	134	137	136	301	300	267	91	145	147	Stable disease
26	138	125	127	181	222	138	77	67	70	Progressive disease
27	134	114	105	544	378	303	49	79	49	Stable disease
Mean ± SD	131 ± 14	117 ± 13	114 ± 14	306 ± 123	263 ± 82	197 ± 70	66 ± 14	100 ± 44	97 ± 45